Furuse, Motomasa
Kuwabara, Hiroko
Ikeda, Naokado
Hattori, Yasuhiko
Ichikawa, Tomotsugu
Kagawa, Naoki
Kikuta, Kenichiro
Tamai, Sho
Nakada, Mitsutoshi
Wakabayashi, Toshihiko
Wanibuchi, Masahiko
Kuroiwa, Toshihiko
Hirose, Yoshinobu
Miyatake, Shin-Ichi https://orcid.org/0000-0001-8056-1016
Funding for this research was provided by:
Bristol-Myers Squibb (none)
Ono Pharmaceutical (none)
Chugai Pharmaceutical (none, none)
Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (none)
Article History
Received: 6 September 2019
Accepted: 13 March 2020
First Online: 5 April 2020
Ethics approval and consent to participate
: The use of materials and clinical data were approved by the institutional ethics committee at Osaka Medical College (Ethics Committee of Osaka Medical College, approval no. 2187). Informed consent for participation in the study was waived by the ethical committees because this study was a retrospective analysis using archived material, and did not increase risk to the patients.
: Not applicable.
: The authors declare that they have no competing interests.